MGX
MGX
NASDAQ · Biotechnology

Metagenomi Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.14
-0.01 (-0.87%)
As of Sep 28, 10:28 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 7 78%
Hold 2 22%
Sell 0 0%
Price Target
Analyst Price Target +2,584.2% upside
Low Target $21.05
Average Target $30.60
High Target $40.98
Current Price $1.14
Current
$1.14
Target
$30.60
$21.05 $30.60 avg $40.98
Scenario Analysis
Bear Case
$21.05
1,746.5%
Low target
Base Case
$30.60
+2,584.2%
Avg target
Bull Case
$40.98
+3,494.7%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$3.95
-71.1% from high
52-Week Low
$1.07
+6.5% from low
50-Day SMA
$1.24
-8.1% vs SMA
RSI (14)
40.6
Neutral
Target vs 52W High
$30.60
+674.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -43.4%